GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » BIO-key International Inc (NAS:BKYI) » Definitions » Equity-to-Asset

BIO-key International (BIO-key International) Equity-to-Asset : 0.34 (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is BIO-key International Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BIO-key International's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $3.31 Mil. BIO-key International's Total Assets for the quarter that ended in Sep. 2023 was $9.75 Mil. Therefore, BIO-key International's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.34.

The historical rank and industry rank for BIO-key International's Equity-to-Asset or its related term are showing as below:

BKYI' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.92   Med: 0.8   Max: 0.91
Current: 0.34

During the past 13 years, the highest Equity to Asset Ratio of BIO-key International was 0.91. The lowest was -0.92. And the median was 0.80.

BKYI's Equity-to-Asset is ranked worse than
70.28% of 1090 companies
in the Business Services industry
Industry Median: 0.49 vs BKYI: 0.34

BIO-key International Equity-to-Asset Historical Data

The historical data trend for BIO-key International's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-key International Equity-to-Asset Chart

BIO-key International Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 -0.92 0.90 0.88 0.47

BIO-key International Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.47 0.46 0.36 0.34

Competitive Comparison of BIO-key International's Equity-to-Asset

For the Security & Protection Services subindustry, BIO-key International's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIO-key International's Equity-to-Asset Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where BIO-key International's Equity-to-Asset falls into.



BIO-key International Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

BIO-key International's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=5.302/11.344
=0.47

BIO-key International's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=3.314/9.749
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIO-key International  (NAS:BKYI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


BIO-key International Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of BIO-key International's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-key International (BIO-key International) Business Description

Traded in Other Exchanges
N/A
Address
3349 Highway 138, Building A, Suite E, Wall, NJ, USA, 07719
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets advanced fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
Executives
Michael W Depasquale director, officer: Co-Chief Executive Officer 1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121
James David Sullivan officer: See Remarks 411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043
Cameron E. Williams director 400 N. CASCADES CIRCLE, CANTON GA 30114
Fong Wong Kwok director FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000
Emmanuel Alia director 15 C SIGNAL HILL ROAD, MADISON CT 06443
Robert J Michel director C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632
Micron Technology Development Ltd 10 percent owner 5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077
Yick Fabian Shin director FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000
Knook Pieter Cornelis director 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Jianhui Yao director SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353
Barbara Rivera director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Thomas Gilley director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Iii Thomas Bush, director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Cecilia C Welch officer: Chief Financial Officer PO BOX 588, DUNSTABLE MA 01827
John Schoenherr director C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803

BIO-key International (BIO-key International) Headlines

From GuruFocus